Otrexup (methotrexate) / Assertio, Antares, Halozyme 
Welcome,         Profile    Billing    Logout  

3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Otrexup (methotrexate) / Assertio
NCT04747912: Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)

Recruiting
2
25
US
Inotuzumab ozogamicin, Besponsa, Dasatinib, SPRYCEL, Dexamethasone, Decadron®, Dexamethasone Intensol®, Dexasone, Solurex®, and Baycadron®, Methotrexate, Otrexup™, Rasuvo®, Rheumatrex® and Trexall™. MTX, Amethopterin, and Methotrexate Sodium, Vincristine, Oncovin and Vincasar Pfs, Ponatinib, Iclusig, Methotrexate for Injection, Allogenic Stem Cell Transplantation
University of Chicago
Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, ph+ Acute Lymphoblastic Leukemia
06/24
05/26
NCT06207123: A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)

Not yet recruiting
1/2
33
US
LP-118, Ponatinib, Iclusig, Vincristine, Oncovin, Vincrex, Vincasar PES, Dexamethasone, DexPak, Decadron, Methotrexate, Otrexup, Xatmep, Rasuvo
University of Chicago
Acute Leukemia, Lymphoblastic Leukemia, Lymphoblastic Lymphoma
12/26
12/26
ALL 001, NCT03962465: Phase I Study of Inotuzumab With Augmented BFM Re-Induction for Patients With Relapsed/Refractory B-cell ALL

Active, not recruiting
1
36
US
Inotuzumab ozogamicin, Besponsa, Prednisone Pill, Deltasone, Daunorubicin, Cerubidine, daunomycin, rubidomycin, Vincristine, Oncovin, Vincasar, Leurocristine, Cytarabine, Ara-C, Cytosar-U, Methotrexate, Otrexup, Rasuvo, Rheumatrex, Trexall, MTX, Amethopterin, Pegaspargase, Oncospar
University of Virginia, Pfizer, Vanderbilt University, University of Wisconsin, Madison, Virginia Commonwealth University
B-cell Acute Lymphoblastic Leukemia
07/23
07/26

Download Options